A gentle workout may fight cancer fatigue
NCT ID NCT07795580
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This trial tests whether low-intensity endurance exercise can reduce cancer-related fatigue and improve sleep, stress, and quality of life in people with lung cancer. Researchers will compare two exercise styles: continuous and interval, both done for 30 minutes a day, five days a week. They will also measure how exercise affects cell health and what personality traits help people stick with the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Low-intensity endurance exercise training, either continuous or interval, performed 30 minutes a day, 5 days a week
- What this could lead to
- If it works, this could point toward a simple, drug-free way to ease fatigue, improve sleep, and boost quality of life for people living with lung cancer.
- What could go wrong
- The trial is early and the benefits are uncertain. Exercise may be hard to stick with, and results may not apply to all lung cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 450 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Jul 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Individuals diagnosed with lung cancer by a physician. 2. Aged 20 years or older. 3. Education level of elementary school graduation or above. Exclusion Criteria: 1. Individuals who are unable to communicate in Mandarin Chinese, Taiwanese, or Hakka. 2. Individuals whose physical condition is determined by a physician to be unsuitable for performing any exercise.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer (diagnosis) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Taipei Medical University
RECRUITINGTaipei, 110, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gentle exercise may revive energy in lung cancer patients
- Laser and AI join forces to spot aggressive lung cancer
- Can a tiny camera help doctors diagnose lung nodules more accurately?
- Laser and AI team up to spot lung cancer in minutes
- Can smarter ventilation during lung surgery prevent complications?
- Which lung biopsy method is safer and more accurate?